An Italian research center has developed an innovative device for the diagnosis of skin tumors (Atomic Force Microscopy based instrument able to measure the mechanical properties of cancer cells). The research group is looking for research collaborations with companies that produce medical analytical devices and nanotechnology/metrology instrumentation. A regional grant can support the co-development of the research results by paying the costs of one year research fellowship.
An Italian research center has developed an innovative device for the diagnosis of skin tumors.
The solution consists of an Atomic Force Microscopy (AFM) inspired instrument for the diagnosis of the malignant character of skin tumors. This new handheld nanoindenter based on AFM technology will be able to measure the relative stiffening of the mole tissue, and will infer its malignity without any surgical tissue sampling.
They are preparing a project proposal that can fund (thanks to a regional programme) one year fellowship grant.
They are looking for a company active in the field of Atomic Force Microscopy based devices (in particular, companies involved in the production of medical analytical devices and nanotechnology/metrology instrumentation) interested in the co-development of the technology.
The company role will be to collaborate with the research group and the dedicated fellow in order to achieve a proof-of-concept potentially ready to be used by the company.
Deadline of the call: 30/08/2017
Deadline for EoIs: 15/07/2017
- Specific area of activity of the partner: Type: companies involved in the production and commercialization of AFM based devices. In particular, companies involved in the production of medical analytical devices and nanotechnology/metrology instrumentation.
Role: co-development of the research results.
The ability to detect the presence of a tumor without the need of a surgical and invasive intervention allows to save time and money; as moles tracking is not required, even a dermatologist at its first inspection may spot malignant moles, also avoiding a surgical operation in the non-malignant cases. The immediate and non-invasive analysis of moles make the test suitable for performing large scale screenings for melanoma.
01/05/2018 - Selling Online Internationally - Shetland
02/05/2018 - Selling Online Internationally - Orkney